Alexander Hartmann Selected Research

Therapeutics

10/2021	Effect of Perioperative Lipid Status on Clinical Outcomes after Cardiac Surgery.
12/2020	Non-invasive brain stimulation as add-on therapy for subacute post-stroke aphasia: a randomized trial (NORTHSTAR).
11/2015	Add-on Effects of Repetitive Transcranial Magnetic Stimulation on Subacute Aphasia Therapy: Enhanced Improvement of Functional Communication and Basic Linguistic Skills. A Randomized Controlled Study.
4/2015	Non-invasive repeated therapeutic stimulation for aphasia recovery: a multilingual, multicenter aphasia trial.
2/2011	Effects of repetitive transcranial magnetic stimulation in aphasic stroke: a randomized controlled pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Hartmann Research Topics

Disease

6	Stroke (Strokes) 10/2021 - 02/2011
6	Aphasia (Dysphasia) 12/2020 - 02/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2017
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2018 - 01/2017
2	Hemorrhage 06/2017 - 12/2013
2	Ischemic Stroke 04/2015 - 08/2013
1	Chronic Disease (Chronic Diseases) 06/2021
1	Nervous System Diseases (Neurological Disorders) 06/2021
1	Infarction (Infarctions) 12/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020
1	Brain Diseases (Brain Disorder) 01/2018
1	Wounds and Injuries (Trauma) 06/2017
1	Brain Infarction 06/2017
1	Hematoma 06/2017
1	Cystic Lymphangioma (Hygroma) 06/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Neuroblastoma 04/2016
1	Thromboembolism 12/2013
1	Endocarditis 12/2013
1	Glucose Intolerance 01/2006
1	Diabetes Mellitus 01/2006
1	Crohn Disease (Crohn's Disease) 01/2006
1	Intracranial Embolism 03/2005
1	Embolism (Embolus) 03/2005
1	Aneurysm (Aneurysms) 03/2005
1	Microaneurysm 03/2005
1	Myxoma (Myxomas) 03/2005

Drug/Important Bio-Agent (IBA)

4	salicylhydroxamic acid (SHAM)IBA 12/2020 - 01/2013
2	Prion ProteinsIBA 01/2018 - 01/2017
2	Amyloid beta-PeptidesIBA 01/2017 - 04/2016
1	oxidized low density lipoproteinIBA 10/2021
1	LipidsIBA 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021
1	Indicators and Reagents (Reagents)IBA 06/2021
1	resolvin D1IBA 10/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Transcription Activator-Like Effector NucleasesIBA 04/2016
1	N 30IBA 11/2015
1	Biological ProductsIBA 12/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2006
1	Insulin (Novolin)FDA Link 01/2006
1	Retinaldehyde (Retinal)IBA 03/2005

Therapy/Procedure

5	Therapeutics 10/2021 - 02/2011
5	Transcranial Magnetic Stimulation 12/2020 - 02/2011
4	Language Therapy (Language Training) 11/2015 - 01/2013
2	Transcranial Direct Current Stimulation 12/2020 - 04/2015
2	Aftercare (After-Treatment) 11/2015 - 08/2013
1	Perioperative Period 10/2021
1	Speech Therapy (Therapy, Speech) 12/2020
1	Decompressive Craniectomy 06/2017
1	Heart Valve Prosthesis 12/2013